Precigen (PGEN) Cash & Equivalents (2016 - 2025)
Historic Cash & Equivalents for Precigen (PGEN) over the last 14 years, with Q3 2025 value amounting to $14.3 million.
- Precigen's Cash & Equivalents fell 4207.48% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year decrease of 4207.48%. This contributed to the annual value of $29.5 million for FY2024, which is 28950.91% up from last year.
- Latest data reveals that Precigen reported Cash & Equivalents of $14.3 million as of Q3 2025, which was down 4207.48% from $13.8 million recorded in Q2 2025.
- Over the past 5 years, Precigen's Cash & Equivalents peaked at $43.8 million during Q2 2022, and registered a low of $4.9 million during Q4 2022.
- Its 5-year average for Cash & Equivalents is $21.0 million, with a median of $16.5 million in 2023.
- Its Cash & Equivalents has fluctuated over the past 5 years, first crashed by 8666.23% in 2022, then surged by 28950.91% in 2024.
- Over the past 5 years, Precigen's Cash & Equivalents (Quarter) stood at $36.4 million in 2021, then tumbled by 86.66% to $4.9 million in 2022, then surged by 55.99% to $7.6 million in 2023, then surged by 289.51% to $29.5 million in 2024, then tumbled by 51.48% to $14.3 million in 2025.
- Its last three reported values are $14.3 million in Q3 2025, $13.8 million for Q2 2025, and $6.1 million during Q1 2025.